Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs / Rogliani, P.; Calzetta, L.. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 22:7(2021), pp. 943-945. [10.1080/14656566.2021.1898746]
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs
Calzetta L.
2021-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
